These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17469345)

  • 1. [Syndrome X vs metabolic syndrome].
    Morales Villegas E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S173-88. PubMed ID: 17469345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome as a cluster of risk factors: is the whole greater than the sum of its parts?: comment on "The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis".
    Ding EL; Smit LA; Hu FB
    Arch Intern Med; 2010 Mar; 170(5):484-5. PubMed ID: 20212187
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic syndrome: one step forward, two steps back.
    Kim SH; Reaven GM
    Diab Vasc Dis Res; 2004 Oct; 1(2):68-75. PubMed ID: 16304726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic options for metabolic syndrome in obese patients].
    Carella AM; Conte M
    Clin Ter; 2007; 158(5):457-64. PubMed ID: 18062354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and its association with colorectal cancer: a review.
    Siddiqui AA
    Am J Med Sci; 2011 Mar; 341(3):227-31. PubMed ID: 20460980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese.
    Zhao D; Grundy SM; Wang W; Liu J; Zeng Z; Wang W; Wu Z
    Am J Cardiol; 2007 Sep; 100(5):835-9. PubMed ID: 17719329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance and metabolic syndrome in first-degree relatives of patients with NIDDM].
    Camps I; Biarnés J; Fernández-Real JM; Insa R; Soler J; Fernández Castañer M
    Med Clin (Barc); 1999 Mar; 112(8):281-4. PubMed ID: 10207842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state.
    Gruber A; Horwood F; Sithole J; Ali NJ; Idris I
    Cardiovasc Diabetol; 2006 Nov; 5():22. PubMed ID: 17078884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of metabolic syndrome in a vascular patient.
    Vykoukal D; Davies MG
    Vascular; 2012 Jun; 20(3):156-65. PubMed ID: 22700582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glucose and insulin patterns during A 5-H glucose tolerance test and association with cardiometabolic risk factors.
    Crespo-Morfin PB; Aguilar-Salinas CA; Almeda-Valdés P; Alfaro-Pastrana R; Bello-Chavolla OY; Cano-Castillo J; Gómez-Pérez FJ; Cruz-Bautista I
    Rev Invest Clin; 2022 Jul; 74(4):193-201. PubMed ID: 35797731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity.
    Brambilla P; Crinò A; Bedogni G; Bosio L; Cappa M; Corrias A; Delvecchio M; Di Candia S; Gargantini L; Grechi E; Iughetti L; Mussa A; Ragusa L; Sacco M; Salvatoni A; Chiumello G; Grugni G;
    Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):269-76. PubMed ID: 20089384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.